Based on the most helpful WSO content, some top-tier early-stage biotech venture capital firms that are known for leading Series A deals and might be interested in first-in-class early stage oncology assets include:

  • Atlas Venture
  • Third Rock
  • 5AM Ventures
  • Flagship Pioneering
  • Orbimed
  • Versant Ventures
  • ARCH Venture Partners

These firms are akin to the MBB (McKinsey, Bain, BCG) or bulge bracket banks of the biotech VC world, often leading the pack in terms of investment in innovative and groundbreaking biotech startups. They are known for their deep scientific expertise and may be more inclined to invest in cutting-edge oncology research rather than more conservative medtech ventures.

Sources: Healthcare / Biotech Venture Capital?, Biotech finance: from IB to VC / HF to funded startup, Guide To Evaluate a Biotech Company, Guide To Evaluate a Biotech Company

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Fugit reprehenderit dolorum fuga suscipit sit occaecati nobis. Qui deleniti est id voluptatem et. Eligendi voluptatem possimus provident accusamus aliquam. Error delectus non culpa incidunt. Laborum enim ut aut rem quos nihil repellat. Quos fuga ad libero officiis asperiores fugiat.

Quos at et adipisci repellendus. Accusamus rerum dicta voluptatum incidunt. Veniam commodi quia sint autem sint magnam inventore.

Est veritatis ut eos alias est sed omnis. Qui adipisci accusantium consectetur occaecati enim qui sit ipsa. Pariatur aut voluptatem cumque aliquam.

Qui quam quos dolores quibusdam ullam. Non est sunt adipisci qui adipisci qui ut.

Career Advancement Opportunities

May 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Perella Weinberg Partners New 98.9%
  • Lazard Freres 01 98.3%
  • Harris Williams & Co. 24 97.7%
  • Goldman Sachs 16 97.1%

Overall Employee Satisfaction

May 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.9%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 05 97.7%
  • Moelis & Company 01 97.1%

Professional Growth Opportunities

May 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.9%
  • Perella Weinberg Partners 18 98.3%
  • Goldman Sachs 16 97.7%
  • Moelis & Company 05 97.1%

Total Avg Compensation

June 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (21) $373
  • Associates (91) $259
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (68) $168
  • 1st Year Analyst (206) $159
  • Intern/Summer Analyst (148) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
Secyh62's picture
Secyh62
99.0
5
GameTheory's picture
GameTheory
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
kanon's picture
kanon
98.9
9
DrApeman's picture
DrApeman
98.8
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”